Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
Oncogene|December 1, 1989
Stage-specific transformation of murine B lineage cells by ras and mycR W Overell, K E Weisser, B Hess, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1989
Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicityD E Kern, K H Grabstein, K Okuno, et al.European Journal of Immunology|August 1, 1990
Induction of B cell activities by interleukin 4 is inhibited by a receptor-specific monoclonal antibody in vitroC R Maliszewski, T A Sato, T Vanden Bos, et al.Immunopharmacology|June 1, 1980
Prevention of the immunosuppressive effects of glucocorticosteroids by cell-free factors from adjuvant-activated accessory cellsR I Mishell, J M Shiigi, B B Mishell, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Immortalization of murine B cells in vitro with oncogene-containing retroviral vectorsK H Grabstein, B Hess, K E Weisser, et al.European Journal of Immunology|October 1, 1994
Interleukin-12 regulates the proliferation of Th1, but not Th2 or Th0, clonesM K Kennedy, K S Picha, K D Shanebeck, et al.International Immunology|July 1, 1996
Differential expression of CD22 (Lyb8) on murine B cellsL D Erickson, L T Tygrett, S K Bhatia, et al.European Journal of Immunology|November 22, 1997
A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cellsP Probst, Y A Skeiky, M Steeves, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 6, 2000
Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: the relative contribution of classical versus nonclassical HLA restrictionD M Lewinsohn, A L Briden, S G Reed, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1993
IL-6 down-modulates the cytokine-enhanced antileishmanial activity in human macrophagesD E Hatzigeorgiou, S He, J Sobel, et al.Pageof 8